Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Institut Curie Strengthens Pioneering Research with Innovative Biobanking Technology

Published: Monday, November 18, 2013
Last Updated: Monday, November 18, 2013
Bookmark and Share
TTP Labtech’s arktic system chosen for technical excellence and provision of long term sample security.

The new phase of expansion for Institut Curie’s Paris-based biobank required a solution for advanced patient sample monitoring, as well as efficient sample storage and preparation across numerous tissue formats, including tumour, RNA, DNA, protein and blood. As part of this upgrade Institut Curie announced today an investment in arktic®, a flexible, modular -80°C sample storage system from a leading technology provider, TTP Labtech.

This platform has been selected by the Institut Curie as part of its longer term strategy encompassing biobank expansion, in particular in the framework of the Equipex initiative conducted by French government of which Institut Curie has been a major laureate. TTP Labtech’s arktic promises to provide a valuable resource for the outstanding oncology research, patient diagnostics and pioneering treatment regimens that the Institut Curie is renowned for. The installation of which is a necessary step to ensure the security of the institute’s invaluable and growing sample repository, and will ensure that issues around sample integrity and availability will not be factors limiting the quality, impact and insight of future research.

Dr. Xavier Sastre-Garau, Director of Pathology at the Institut Curie commented: “We have been impressed with the level of scientific innovation and engineering know-how provided by the TTP Labtech team. We required a future-proofed system that had the flexibility to grow as our biobank expanded, could store a range of different sample types and volumes and could facilitate better sample management and tracking. TTP Labtech’s arktic has provided a solution to these requirements. The small footprint of the arktic also greatly aids our facility design and set-up and allows us to make the best use of our space.” 

James Craven, Commercial Head of Sample Management at TTP Labtech commented, “We are honoured to have been chosen by Institut Curie at this very critical phase of expansion.  The Institut curie provides invaluable research in the fight against Cancer”. TTP Labtech’s arktic storage modules have no moving parts within the cold zone. Instead, internal sample transport relies on its proprietary pneumatic technology, greatly improving the efficiency and mechanical reliability of the system.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

TTP Labtech Revenues up 43%
The company has reported an impressive 43% increase in revenues and an associated increase in profits over 2013.
Monday, June 23, 2014
TTP LabTech to present “Genome-Wide siRNAi Screening” tutorial at RNAi Europe
TTP LabTech will be presenting a tutorial on ‘Genome-Wide siRNAi Screening Using the Acumen eX3 – A Customer Perspective from Cancer Research UK’ on Thursday 17th September at the RNAi Europe 2009 conference.
Thursday, August 20, 2009
Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!